Ads

 

Ads

 

Ads

 

Top Healthcare Companies in Europe List by Market Cap as of August 2026

Top Healthcare Companies in Europe List by Market Cap as of August 2026. Biggest and Top Healthcare Companies in Europe Companies by Market Cap. Largest Top Healthcare Companies in Europe List by Market Cap as of August 2026.
Metatag Title
Top Healthcare Companies in Europe
Metatag Abstract
Top Healthcare Companies in Europe, Biggest Healthcare Companies in Europe, Largest Healthcare Companies in Europe.
  1. Qiagen

    World Rank (Aug-2026)
    2,413
    Market Cap (Aug-2026)
    8.851 Billion USD
    World Rank (Jan-05-2024)
    1,657
    Market Cap (Jan-05-2024)
    9.994 Billion USD
    World Rank (Jul-30-2023)
    1,592
    Market Cap (Jul-30-2023)
    10.745 Billion USD
    World Rank (Dec-25-2022)
    1,395
    Market Cap (Dec-25-2022)
    11.228 Billion USD
    World Rank (Jan-07-2022)
    1,676
    Market Cap (Jan-07-2022)
    11.46 Billion USD
    Annual Revenue in USD
    2,141 Million USD
    Annual Operating Income in USD
    576 Million USD
    Annual Net Income in USD
    423 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical and research company with headquarters is in Germany.

  2. Alk-Abello A/S

    World Rank (Aug-2026)
    2,522
    Market Cap (Aug-2026)
    8.308 Billion USD
    World Rank (Jan-05-2024)
    4,133
    Market Cap (Jan-05-2024)
    3.246 Billion USD
    World Rank (Jul-30-2023)
    5,183
    Market Cap (Jul-30-2023)
    2.344 Billion USD
    World Rank (Dec-25-2022)
    4,071
    Market Cap (Dec-25-2022)
    3.007 Billion USD
    World Rank (Jan-07-2022)
    3,110
    Market Cap (Jan-07-2022)
    5.34 Billion USD
    Annual Revenue in USD
    580 Million USD
    Annual Net Income in USD
    32 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ALK-Abello A/S is a Pharmaceutical company. The headquarters is in Denmark.
  3. Alkermes

    World Rank (Aug-2026)
    2,545
    Market Cap (Aug-2026)
    8.230 Billion USD
    World Rank (Jan-05-2024)
    3,032
    Market Cap (Jan-05-2024)
    4.784 Billion USD
    World Rank (Jul-30-2023)
    3,088
    Market Cap (Jul-30-2023)
    4.778 Billion USD
    World Rank (Dec-25-2022)
    3,161
    Market Cap (Dec-25-2022)
    4.188 Billion USD
    World Rank (Jan-07-2022)
    3,992
    Market Cap (Jan-07-2022)
    3.88 Billion USD
    Annual Revenue in USD
    1,111 Million USD
    Annual Operating Income in USD
    -142 Million USD
    Annual Net Income in USD
    -158 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. Headquarters is in Dublin, Ireland.

    Alkermes seeks to develop innovative medicines that help address the unmet needs and challenges of people living with debilitating diseases.

    The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer.

  4. Grifols S.A.

    World Rank (Aug-2026)
    2,630
    Market Cap (Aug-2026)
    7.879 Billion USD
    World Rank (Jan-05-2024)
    1,723
    Market Cap (Jan-05-2024)
    9.535 Billion USD
    World Rank (Jul-30-2023)
    1,788
    Market Cap (Jul-30-2023)
    9.235 Billion USD
    World Rank (Dec-25-2022)
    2,512
    Market Cap (Dec-25-2022)
    5.513 Billion USD
    World Rank (Jan-07-2022)
    1,735
    Market Cap (Jan-07-2022)
    11.02 Billion USD
    Annual Revenue in USD
    6,685 Million USD
    Annual Operating Income in USD
    774 Million USD
    Annual Net Income in USD
    229 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical and healthcare company with headquarters is in Barcelona, Spain.

  5. Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo

    World Rank (Aug-2026)
    2,712
    Market Cap (Aug-2026)
    7.550 Billion USD
    World Rank (Jan-05-2024)
    2,938
    Market Cap (Jan-05-2024)
    4.970 Billion USD
    World Rank (Jul-30-2023)
    3,151
    Market Cap (Jul-30-2023)
    4.687 Billion USD
    World Rank (Dec-25-2022)
    3,044
    Market Cap (Dec-25-2022)
    4.392 Billion USD
    World Rank (Jan-07-2022)
    3,270
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    2,269 Million USD
    Annual Operating Income in USD
    538 Million USD
    Annual Net Income in USD
    439 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO is a Specialty Pharmaceutical company focused on therapies across a number of cardiovascular diseases there is an increased demand to osteoporosis and rheumatic diseases. The headquarters is in Hungary.

  6. Abcam

    World Rank (Aug-2026)
    2,771
    World Rank (Jan-05-2024)
    2,771
    World Rank (Jul-30-2023)
    2,771
    Market Cap (Jul-30-2023)
    5.396 Billion USD
    World Rank (Dec-25-2022)
    3,615
    Market Cap (Dec-25-2022)
    3.542 Billion USD
    World Rank (Jan-07-2022)
    3,422
    Market Cap (Jan-07-2022)
    4.75 Billion USD
    Annual Revenue in USD
    457 Million USD
    Annual Operating Income in USD
    -13 Million USD
    Annual Net Income in USD
    -10 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile

    Abcam is a Biological Reagents company. It is essential in a wide range of fields and applications including drug discovery, diagnostics and basic research and present across eleven sites globally. The headquarters is in UK.

    Abcam is the leading Supplier of Protein Research Tools to Life Scientists company. The company annual revenue is 316.8 million USD and 1,492 employees as on 2019.

    Danaher has acquired Abcam for 5.7 billion USD in 2023.

    Facts About Company

    Abcam annual revenue was 361 million GBP and annual net loss was -8 million GBP generated for period year ending Dec-2022.

    Abcam annual revenue was 315 million GBP and annual net income was 4 million GBP generated for period year ending Dec-2021.

    As on 2022, Abcam had 1760 employees.

  7. Getinge AB

    World Rank (Aug-2026)
    2,854
    Market Cap (Aug-2026)
    7.032 Billion USD
    World Rank (Jan-05-2024)
    2,562
    Market Cap (Jan-05-2024)
    5.916 Billion USD
    World Rank (Jul-30-2023)
    2,931
    Market Cap (Jul-30-2023)
    5.087 Billion USD
    World Rank (Dec-25-2022)
    2,531
    Market Cap (Dec-25-2022)
    5.477 Billion USD
    World Rank (Jan-07-2022)
    1,768
    Market Cap (Jan-07-2022)
    10.83 Billion USD
    Annual Revenue in USD
    2,682 Million USD
    Annual Operating Income in USD
    368 Million USD
    Annual Net Income in USD
    236 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Getinge AB is a Healthcare company. It is having more than 10,000 employees, operations in 38 countries and sales in more than 135 countries. The company offering includes solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The headquarters is in Sweden.

  8. Ypsomed Holding AG

    World Rank (Aug-2026)
    2,965
    Market Cap (Aug-2026)
    6.640 Billion USD
    World Rank (Jan-05-2024)
    3,045
    Market Cap (Jan-05-2024)
    4.753 Billion USD
    World Rank (Jul-30-2023)
    3,500
    Market Cap (Jul-30-2023)
    4.038 Billion USD
    World Rank (Dec-25-2022)
    4,617
    Market Cap (Dec-25-2022)
    2.542 Billion USD
    World Rank (Jan-07-2022)
    5,468
    Market Cap (Jan-07-2022)
    2.51 Billion USD
    Annual Revenue in USD
    571 Million USD
    Annual Operating Income in USD
    69 Million USD
    Annual Net Income in USD
    59 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Ypsomed Holding AG is the leading developer and manufacturer of injection and infusion systems company for self medication and a renowned diabetes specialist. It is having around 1,900 employees worldwide. The company annual revenue is 403.6 million CHF, annual net income is 5.8 million CHF and total assets are 717.6 million CHF as on 2021. The headquarters is in Switzerland.
  9. H. Lundbeck A/S

    World Rank (Aug-2026)
    3,085
    Market Cap (Aug-2026)
    6.288 Billion USD
    World Rank (Jan-05-2024)
    3,042
    Market Cap (Jan-05-2024)
    4.760 Billion USD
    World Rank (Jul-30-2023)
    3,123
    Market Cap (Jul-30-2023)
    4.724 Billion USD
    World Rank (Dec-25-2022)
    3,498
    Market Cap (Dec-25-2022)
    3.704 Billion USD
    World Rank (Jan-07-2022)
    3,323
    Market Cap (Jan-07-2022)
    4.91 Billion USD
    Annual Revenue in USD
    2,697 Million USD
    Annual Operating Income in USD
    422 Million USD
    Annual Net Income in USD
    283 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Lundbeck is a global pharmaceutical company specialized in brain diseases. Headquarters is in Denmark.

    Lundbeck employs approximately 5,800 employees in more than 50 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and California.

  10. Convatec Group

    World Rank (Aug-2026)
    3,164
    Market Cap (Aug-2026)
    6.087 Billion USD
    World Rank (Jan-05-2024)
    2,433
    Market Cap (Jan-05-2024)
    6.341 Billion USD
    World Rank (Jul-30-2023)
    2,737
    Market Cap (Jul-30-2023)
    5.491 Billion USD
    World Rank (Dec-25-2022)
    2,433
    Market Cap (Dec-25-2022)
    5.726 Billion USD
    World Rank (Jan-07-2022)
    3,166
    Market Cap (Jan-07-2022)
    5.23 Billion USD
    Annual Revenue in USD
    2,072 Million USD
    Annual Operating Income in USD
    221 Million USD
    Annual Net Income in USD
    63 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    ConvaTec Group is a Medical Products and Technologies Company. It products provide a range of clinical and economic benefits including infection prevention, protection of at risk skin, improved patient outcomes and reduced total cost of care. It is having 9,400 employees and business in more than 110 countries. The headquarters is in UK.

    Facts About Company

    ConvaTec Group annual revenue was 2,072 million GBP and annual net income was 62 million GBP generated for period year ending Dec-2022.

    ConvaTec Group annual revenue was 2,038 million GBP and annual net income was 117 million GBP generated for period year ending Dec-2021.

    As on 2022, ConvaTec Group had 10000 employees.

Share

Ads